对比增强乳腺X线摄影在乳腺导管原位癌术前检出中的作用:与低能图像和磁共振成像的比较
单中心回顾性研究纳入96例患者98个纯导管原位癌病灶,术前2周内行对比增强乳腺X线摄影和磁共振成像。对比增强乳腺X线摄影对导管原位癌的敏感度与磁共振成像相似(92.9% vs 93.9%),显著高于单独低能图像(76.5%);对非钙化导管原位癌,对比增强乳腺X线摄影敏感度显著高于低能图像(93.8% vs 43.8%),与磁共振成像相似(93.8%)。
要点
- 对比增强乳腺X线摄影对导管原位癌敏感度92.9%,与磁共振成像93.9%相似,显著高于低能图像76.5%。
- 非钙化导管原位癌中,对比增强乳腺X线摄影敏感度93.8%,显著高于低能图像43.8%,与磁共振成像93.8%相似。
- 病灶大小与病理大小差异磁共振成像最小,对比增强乳腺X线摄影次之,低能图像最大。
核心结论
- 对比增强乳腺X线摄影诊断导管原位癌的敏感度高于单独低能图像,与磁共振成像相当;对比增强乳腺X线摄影显示的强化形态与磁共振成像一致;在导管原位癌大小测量上对比增强乳腺X线摄影优于单独低能图像。
研究设计与样本
- 单中心回顾性研究,纳入96例患者共98个纯导管原位癌病灶,术前2周内行对比增强乳腺X线摄影和磁共振成像检查。
关键影像表现/征象
- 磁共振成像中所有导管原位癌病灶均强化,对比增强乳腺X线摄影中94.9%(93/98)病灶强化。
- 非肿块强化是最常见表现,对比增强乳腺X线摄影占63.4%,磁共振成像占66.3%。
- 对比增强乳腺X线摄影有助于同时比较钙化与强化。
诊断标准与关键数值
- 对比增强乳腺X线摄影对导管原位癌敏感度92.9%,磁共振成像93.9%,两者差异无统计学意义(p=0.77)。
- 对比增强乳腺X线摄影敏感度显著高于单独低能图像76.5%(p=0.002)。
- 钙化型导管原位癌中,对比增强乳腺X线摄影敏感度92.4%,单独低能图像92.4%,磁共振成像93.9%,差异无统计学意义(p=1.00)。
- 非钙化型导管原位癌中,对比增强乳腺X线摄影敏感度93.8%,显著高于单独低能图像43.8%(p<0.001),与磁共振成像93.8%相似(p=1.00)。
临床应用与阅片要点
- 对比增强乳腺X线摄影可用于术前评估导管原位癌,尤其对非钙化病灶检出敏感度显著高于单独低能图像。
- 对比增强乳腺X线摄影可同时显示钙化与强化,有助于钙化型导管原位癌的评估。
- 病灶大小测量以磁共振成像最接近病理,对比增强乳腺X线摄影次之,低能图像差异最大。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare contrast-enhanced mammography (CEM) with low-energy image (LEI) alone and with magnetic resonance imaging (MRI) in the preoperative diagnosis of ductal carcinoma in situ (DCIS).
METHODS: In this single-center retrospective study, we reviewed 98 pure DCIS lesions in 96 patients who underwent CEM and MRI within 2 weeks preoperatively. The diagnostic performances of each imaging modality, lesion morphology, and extent were evaluated.
RESULTS: The sensitivity of CEM to DCIS was similar to that of MRI (92.9% vs. 93.9%, p = 0.77) and was significantly higher than that of LEI alone (76.5%, p = 0.002). The sensitivity of CEM to calcified DCIS (92.4%) was not significantly different from LEI alone (92.4%) and from MRI (93.9%, p = 1.00). However, CEM contributed to the simultaneous comparison of calcifications with enhancements. CEM had considerably higher sensitivity compared with LEI alone (93.8% vs. 43.8%, p < 0.001) and performed similarly to MRI (93.8%, p = 1.00) for noncalcified DCIS. All DCIS lesions were enhanced in MRI, whereas 94.9% (93/98) were enhanced in CEM. Non-mass enhancement was the most common presentation (CEM 63.4% and MRI 66.3%). The difference between the lesion size on each imaging modality and the histopathological size was smallest in MRI, followed by CEM, and largest in LEI.
CONCLUSION: CEM was more sensitive than LEI alone and comparable to MRI in DCIS diagnosis. The enhanced morphology of DCIS in CEM was consistent with that in MRI. CEM was superior to LEI alone in size measurement of DCIS.
CLINICAL RELEVANCE STATEMENT: This study investigated the value of CEM in the diagnosis and evaluation of DCIS, aiming to offer a reference for the selection of examination methods for DCIS and contribute to the early diagnosis and precise treatment of DCIS.
KEY POINTS: • DCIS is an important indication for breast surgery. Early and accurate diagnosis is crucial for DCIS treatment and prognosis. • CEM overcomes the deficiency of mammography in noncalcified DCIS diagnosis, exhibiting similar sensitivity to MRI; and CEM contributes to the comparison of calcification and enhancement of calcified DCIS, thereby outperforming MRI. • CEM is superior to LEI alone and slightly inferior to MRI in the size evaluation of DCIS.
引用
- Wang L, Wang P, Shao H, et al. Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging. Eur Radiol. 2023. PMID: 37853174. doi:10.1007/s00330-023-10312-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。